Genetic clue to fighting new strains of flu

by Anne Rahilly
Genetic clue to fighting new strains of flu

(Medical Xpress)—Researchers at the University of Melbourne have discovered a genetic marker that can accurately predict which patients will experience more severe disease in a new strain of influenza (H7N9) currently found in China.

Published in the Journal Proceedings of the National Academy of Sciences, senior author, Associate Professor Katherine Kedzierska from the Department of Microbiology and Immunology said that being able to predict which patients will be more susceptible to the emerging , will allow clinicians to better manage an early intervention strategy.

"By using genetic markers to blood and lung samples, we have discovered that there are certain indicators that signal increased susceptibility to this influenza. Higher than normal levels of cytokines, driven by a genetic variant of a protein called IFITM3, tells us that the severe disease is likely," she said.

"We call this a Cytokine Storm and people with the defective genetic variant of the protein IFITM3 are more likely to succumb to severe influenza infection.

Professor Peter Doherty, AC, Laureate Professor and a lead author of the study from the University of Melbourne said predicting how influenza works in individuals has implications for the management of disease and the resources on our health system.

"We are exploring how genetic sequencing and early identification can allow us to intervene in treating patients before they become too unwell. As new cases of emerge in the Northern Hemisphere, we try to keep a season ahead and prepare to protect the most vulnerable in our community," he said.

Though the H7N9 strain has not been found in Australia, researchers from the University of Melbourne are collaborating closely with Prof Jianqing Xu and his group from the Shanghai Public Health Clinical Center in China. In addition to this, Dr Zhongfang Wang, an NHMRC Australian-China Exchange Fellow is also working closely with Melbourne experts.

More information: "Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection," by Zhongfang Wang et al. www.pnas.org/cgi/doi/10.1073/pnas.1321748111

Related Stories

New findings into conquering influenza

Jan 29, 2013

Reseachers from the University of Melbourne and The Walter and Eliza Hall Institute (WEHI) have discovered a new protein that protects against viral infections such as influenza.

Recommended for you

Global Ebola toll rises to 5,689: WHO

3 hours ago

The World Health Organization said Thursday that the global death toll from the Ebola virus had increased to 5,689 out of a total of 15,935 cases of infection, mainly in western Africa.

Ebola vaccine promising in first human trials

14 hours ago

Researchers say they're a step closer to developing an Ebola vaccine, with a Phase 1 trial showing promising results, but it will be months at the earliest before it can be used in the field.

At one month, US Ebola monitors finding no cases

17 hours ago

The U.S. program that requires weeks of monitoring for travelers from African countries with Ebola reaches the one-month mark Thursday. And so far, no cases of the disease have turned up.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.